Ken Fisher’s MDT Holdings & Trades

First Buy
Q1 2015
Duration Held
43 Quarters
Largest Add
Q1 2020
+918,007 Shares
Current Position
239,529 Shares
$22.81 M Value

Ken Fisher's MDT Position Overview

Ken Fisher (via Fisher Asset Management, LLC) currently holds 239,529 shares of Medtronic plc (MDT) worth $22.81 M, representing 0.01% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.

Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2020, adding 918,007 shares. Largest reduction occurred in Q1 2025, reducing 5.16 M shares.

Analysis based on 13F filings available since 2013 Q2

Ken Fisher's Medtronic plc (MDT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Medtronic plc (MDT) Trades by Ken Fisher

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2015 +6,717 New Buy 6,717 $78.01
Q2 2015 -272 Reduce 4.05% 6,445 $74.17
Q3 2015 -506 Reduce 7.85% 5,939 $67.01
Q4 2015 -34 Reduce 0.57% 5,905 $76.88
Q1 2016 -887 Reduce 15.02% 5,018 $77.12
Q2 2016 -302 Reduce 6.02% 4,716 $88.42
Q3 2016 +233 Add 4.94% 4,949 $86.48
Q4 2016 +1,147 Add 23.18% 6,096 $71.19
Q1 2017 +1,013 Add 16.62% 7,109 $80.60
Q2 2017 +176,656 Add 2484.96% 183,765 $88.75
Q3 2017 +5,147 Add 2.80% 188,912 $77.77
Q4 2017 -24,714 Reduce 13.08% 164,198 $80.75
Q1 2018 +52,758 Add 32.13% 216,956 $80.22
Q2 2018 +9,787 Add 4.51% 226,743 $85.61
Q3 2018 +7,073 Add 3.12% 233,816 $98.37
Q4 2018 +16,420 Add 7.02% 250,236 $90.96
Q1 2019 +10,601 Add 4.24% 260,837 $91.08
Q2 2019 -34,164 Reduce 13.10% 226,673 $97.39
Q3 2019 +7,388 Add 3.26% 234,061 $108.62
Q4 2019 -70,269 Reduce 30.02% 163,792 $113.45
Q1 2020 +918,007 Add 560.47% 1.08 M $90.18
Q2 2020 +494,504 Add 45.71% 1.58 M $91.70
Q3 2020 +231,537 Add 14.69% 1.81 M $103.92
Q4 2020 +162,871 Add 9.01% 1.97 M $117.14
Q1 2021 +148,876 Add 7.55% 2.12 M $118.13
Q2 2021 +163,838 Add 7.73% 2.28 M $124.13
Q3 2021 +147,644 Add 6.47% 2.43 M $125.35
Q4 2021 +165,427 Add 6.80% 2.6 M $103.45
Q1 2022 +176,360 Add 6.79% 2.77 M $110.95
Q2 2022 +222,954 Add 8.04% 3 M $89.75
Q3 2022 +164,915 Add 5.50% 3.16 M $80.75
Q4 2022 +142,606 Add 4.51% 3.3 M $77.72
Q1 2023 +117,279 Add 3.55% 3.42 M $80.65
Q2 2023 -158,101 Reduce 4.62% 3.26 M $88.10
Q3 2023 +496,540 Add 15.22% 3.76 M $78.36
Q4 2023 +833,410 Add 22.17% 4.59 M $82.38
Q1 2024 +335,964 Add 7.32% 4.93 M $87.15
Q2 2024 +355,906 Add 7.22% 5.28 M $78.71
Q3 2024 +609,391 Add 11.53% 5.89 M $90.03
Q4 2024 +179,845 Add 3.05% 6.07 M $79.88
Q1 2025 -5.16 M Reduce 84.98% 912,512 $89.86
Q2 2025 -638,446 Reduce 69.97% 274,066 $87.17
Q3 2025 -34,537 Reduce 12.60% 239,529 $95.24

Ken Fisher's Medtronic plc Investment FAQs

Ken Fisher first purchased Medtronic plc (MDT) in Q1 2015, acquiring 6,717 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher's largest addition to Medtronic plc (MDT) was in Q1 2020, adding 1,081,799 shares worth $97.56 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 239,529 shares of Medtronic plc (MDT), valued at approximately $22.81 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher's peak holding in Medtronic plc (MDT) was 6,073,565 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.